ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals, established in 2006, developed a proprietary platform for oral delivery of drugs typically administered by injection. Their flagship product is oral insulin (ORMD-0801) for type 2 diabetes, with ongoing clinical trials under the FDA, and ORMD-0901, an oral GLP-1 analog. Oramed aims to improve lives worldwide by transforming injectable treatments into oral therapies.
Registro Oficial
Análisis de Calidad IA
Desglose de Puntuación de Confianza
Enlaces Rápidos
Destacados del sitio web
🌟 Empresas similares de confianza
Lantern Pharma Inc.
Lantern Pharma is an AI-driven company focused on transforming oncology drug discovery and development. Leveraging their proprietary RADR® platform, which utilizes ~200 billion oncology-focused data points and advanced ML algorithms, they accelerate the creation of precision therapies. Their pipeline includes drug candidates across multiple cancer indications, with one in Phase 2 clinical testing, aiming to reduce costs and timelines. They collaborate with various institutions to advance their AI precision oncology platform.
Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals aims to be a leading innovator in the self-care market, driving expanded access to key prescription pharmaceuticals as Over-the-Counter treatment options. They focus on enhancing consumer reach to medications via OTC drug programs and democratizing healthcare by making medications more accessible without a prescription.
OVATION SCIENCE INC.
Ovation Science Inc. is capitalizing on its patented Invisicare® skin delivery technology, disrupting the topical market with its advanced science. They provide pharmaceutical-grade technology to global licensees, resulting in high-quality, efficacious topical and transdermal products. The company is an innovative player in drug delivery systems.